文献速递免疫规划

印度成人肺炎球菌基线IgG抗体水平及对23价肺炎球菌多糖疫苗的免疫应答

Pneumococcal baseline IgG antibody levels and immune response to 23-valent pneumococcal polysaccharide vaccine among Indian adults.
PubMed 文献 · Vaccine · 2025-12-23

研究采用WHO-ELISA法检测51名健康印度成人接种23价肺炎球菌多糖疫苗(PPSV23)前后的型特异性IgG抗体水平,基线几何平均浓度对约83%的荚膜多糖(CPS)型别充足(≥1.3 μg/mL),接种后23种CPS型别中22种的IgG抗体水平显著升高,中位数范围为2.3至57.8 μg/mL。

要点

  • 基线几何平均浓度对约83%的荚膜多糖型别≥1.3 μg/mL,血清型14、15B、19A和33F水平较高。
  • 接种后23种荚膜多糖型别中22种的IgG抗体水平显著升高,中位数范围为2.3至57.8 μg/mL。
  • 荚膜多糖型别7F、9N、8和33F的几何平均倍数升高最高(约6至9倍)。

核心结论

  • 研究结果强调PPSV23能够增强印度成人针对肺炎球菌疾病的保护性免疫,支持继续使用该疫苗。
  • 需要进一步研究以优化疫苗接种策略并评估诱导抗体的功能活性。

研究设计与样本

  • 研究采用WHO-ELISA法检测51名健康印度成人接种23价肺炎球菌多糖疫苗(PPSV23)前后的型特异性IgG抗体水平。

主要发现

  • 基线几何平均浓度对约83%的荚膜多糖(CPS)型别充足(≥1.3 μg/mL),血清型14、15B、19A和33F水平显著较高。
  • 接种后,23种CPS型别中22种的IgG抗体水平显著升高,中位数范围为2.3至57.8 μg/mL。
  • 荚膜多糖型别7F、9N、8和33F的几何平均倍数升高最高(约6至9倍)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需要进一步研究以优化疫苗接种策略并评估诱导抗体的功能活性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Measuring immune responses to pneumococcal vaccines is crucial for evaluating their impact and efficacy. Herein, we measured type-specific IgG antibody levels before and after immunization with the 23-valent pneumococcal polysaccharide vaccine (PPSV23) in 51 healthy Indian adults using WHO-ELISA. Baseline geometric mean concentrations were adequate (≥1.3 μg/mL) against ∼83% of the capsule polysaccharide (CPS) types, with notably higher levels for serotypes 14, 15B, 19A, and 33F. Post-vaccination, IgG antibody levels significantly increased for 22 of 23 CPS types, with medians ranging from 2.3 to 57.8 μg/mL. The highest geometric mean fold rise (∼6 to 9-fold) was observed for CPS types 7F, 9N, 8, and 33F. The findings highlight the capability of PPSV23 to strengthen protective immunity against pneumococcal disease in Indian adults, advocating for its continued use. Further studies are needed to optimize vaccination strategies and evaluate the functional activity of induced antibodies.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Ramakrishnan SM, Ganaie FA, Govindan V, et al. Pneumococcal baseline IgG antibody levels and immune response to 23-valent pneumococcal polysaccharide vaccine among Indian adults. Vaccine. 2025. PMID: 41442862. doi:10.1016/j.vaccine.2025.128157

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。